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Willingness-to-pay Against Dementia 
Abstract 
Objectives: Preferences of both Alzheimer patients and their spouse caregivers are related 
to a willingness-to-pay (WTP) measure which is used to test for the presence of mutual 
(rather than the conventional one-way) altruism. 
Methods: Identical contingent valuation interviews were conducted in 2000 - 2002 for 126 
Alzheimer patients and their caregiving spouses living in the Zurich metropolitan area 
(Switzerland). We elicit WTP three hypothetical treatments of the demented patient. The 
treatment Stabilization prevents the worsening of the disease, bringing dementia to a 
standstill. Cure restores patient health to its original level. In No burden, dementia takes its 
normal course while caregiver’s burden is reduced to its level before the disease.  
Results: Different characteristics of therapies are reflected in differences in WTP values. 
Accepting WTP values as expression of preferences, one finds that patients do not rank 
Cure higher than No burden; implying that their WTP is entirely altruistic. Caregiving 
spouses rank Cure before Burden, some 40 percent of their WTP reflecting an altruistic 
motive again.  
Discussion: The evidence suggests that WTP values are reliable measures of subjective 
preferences even in Alzheimer patients. Using this indicator, it is found that only 






Dementia refers to a group of diseases characterized by progressive deterioration in 
cognitive function. The symptoms are memory loss, disorientation, and inappropriate 
social behavior. Alzheimer’s disease is the most common type of dementia. Informal care 
(usually by the spouse) constitutes a major part of care provided to patients with dementia. 
It is a well-established fact that providing care for a person with dementia is stressful and 
demanding (Bédard et al. 2000; Whitlatch 1998). Therefore, dementia affects two persons: 
the patient and the caregiving relative.   
Curing dementia has two main effects. First, it improves the health status of the patient. 
Second, it reduces caregiver’s burden and time needed to take care for the patient (see 
Figure 1). Patients and caregivers are affected differently by these two effects. The first 
concerns directly the patients, whereas the second accrues to the caregiver. The basic 
hypothesis to be tested in this paper is that these differences translate into differences in 
economic valuation, measured as willingness-to-pay (WTP). If this hypothesis can be 
accepted, the proposition to be tested is that WTP values reflect mutual altruism; indeed, 
patients may care about caregiver’s burden and caregivers may worry about the patient’s 
well-being (for an economic formulation of altruism, see Arana and Leon 2002). If the 
patient should value the reduced burden of the caregiver (the indirect effect in Figure 1), 
this would reflect altruism. To the extent that the caregiver values the improved health 
status of the patient, this could be a component of WTP due to altruism on his or her part. 
The objectives of this study thus are twofold, finding out whether the effects of treating 
dementia translate into WTP, and using WTP for testing for the presence of altruism 
specifically of husbands and wives in the presence of a fatal disease.  
*** Figure 1 *** 
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Contingent valuation is increasingly used in health care to measure the value of non-
market goods (Diener, O'Brien & Gafni, 1998; Klose 1999; Olsen & Smith 2001). It is 
based on asking persons directly about the amount they are willing to pay to reduce the risk 
of death or improve the quality of life. Most contingent valuation studies have estimated 
the value of an improvement of individuals’ own health. Only few studies have examined 
WTP to protect another person’s health (Agee & Crocker 1996; Liu, Hammitt, Wang and 
Lin, 2000; Viscusi, Magat & Huber, 1987). All of them estimate parents’ WTP for the 
health of their children. For example, Liu et al. (2000) show that a mother’s WTP to 
prevent her child from suffering a cold is about twice as large as her WTP to prevent 
herself from suffering a cold of comparable duration and severity. By way of contrast, this 
study seeks to determine WTP of both the caregiver and the patient for both the patient’s 
health and the reduction of caregiver’s burden. We are not aware of another study that 
distinguishes these two components of WTP in both the patient and his or her caregiver. 
Two recent publications have used contingent valuation to estimate WTP in the context 
of dementia (König & Wettstein 2002; Nocera, Bonato & Telser, 2002). Nocera et al. 
(2002) base their investigation on responses from the general population to find out 
whether three programs against Alzheimer’s Disease should be implemented from a 
societal point of view. Using the same data as this study, König & Wettstein (2002) 
analyze only caregivers’ WTP. They estimate the WTP of informal caregivers for a 
reduction of their burden and conclude that caregiver’s disutility from this burden is 
considerable. 
The remainder of the paper is organized as follows. The next section presents 
hypotheses with regard to the ranking of treatments and differences between WTP of 
patients and caregivers. This is followed by a description of survey method and data. The 
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fourth presents the aggregate WTP estimates that permit tests of the two maintained 
hypotheses. In the final section of the paper, some concluding remarks are offered.  
Methods 
Hypotheses to be tested 
We elicit WTP for three hypothetical treatments of the demented patient (for their 
description, see Exhibit). The first (Stabilization) prevents the worsening of the disease, 
bringing dementia to a standstill. The interviewer explicitly informs the interviewee that 
the treatment leads to no improvement in the health state of the patient. In the second case 
(Cure), caregivers and patients are asked about their WTP for a hypothetical treatment that 
restores health status to its original level. The time required for care and the burden of the 
caregiver are reduced to the level before the disease. In the third case (No burden), 
dementia takes its normal course while caregiver’s burden is reduced to its level before the 
disease.  
*** Exhibit here *** 
In all three cases, the respondents were told that the hypothetical treatment was 
expensive but not covered by health insurance. Therefore, they would have to pay it out of 
their pocket. Outcomes were presented as being certain and due to treatment (rather than 
behavioral adjustment). 
Assuming egoism on the part of both patients and caregivers, the following rankings of 
treatments can be hypothesized. 
HTE (Ranking of treatments, given egoism):  
Patients’ WTP:  Cure > Stabilization > No burden 
Caregivers’ WTP:  No burden = Cure > Stabilization 
 5
The first ranking follows directly from the differences in health status. The second ranking 
derives from the fact that No burden and Cure offer the same relief to the caregiver. Both 
are in terms of WTP values, which presupposes that WTP constitutes a reliable measure of 
preferences. 
Assumption: Assume that the WTP values do not differ in a general way between patients 
and caregivers (such that e.g. patients value all alternatives five times 
higher).  
Then, the following hypotheses can additionally be derived from HTE. 
HDE (Differences between patients and caregivers, given egoism): 
Stabilization:  WTP of patients > WTP of caregivers 
Cure:   WTP of patients > WTP of caregivers 
No burden:  WTP of patients < WTP of caregivers 
These differences can be justified by noting that patients are more directly affected than 
caregivers by the treatment alternatives that improve their health status (see Figure 1), viz. 
Stabilization and Cure. In the case of No burden, however, there is no benefit to the patient 
at all. 
These hypotheses may be contrasted to those that obtain if both patients and caregivers are 
so perfectly altruistic as to fully adopt the other’s point of view. This means that patients 
display the HTE of caregivers, while caregivers display the HTE of patients. 
HTA (Ranking of treatments, given altruism): 
Patients’ WTP : No burden = Cure > Stabilization 
Caregivers’ WTP: Cure > Stabilization > No burden 
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If again WTP values are of similar magnitude in general (if the Assumption stated above 
holds), the HDE ranking above can be reversed to yield, 
HDA (Differences between patients and caregivers, given altruism): 
Stabilization:  WTP of patients < WTP of caregivers 
Cure:   WTP of patients < WTP of caregivers 
No burden:  WTP of patients > WTP of caregivers 
The differences between the HTE and HTA rankings and the HDE and HDA rankings, 
respectively, will be exploited below to test for the presence of altruism. 
Survey and WTP questions 
The data set used in this paper comes from a larger study on ‘Effects of training relative 
caregivers of patients with dementia’. It includes only patients in the mild to moderate 
stage of the disease because the training offered to spouse caregivers is thought to be 
ineffective for patients in the severe stage. The WTP questions analyzed below were 
developed with survey specialists and gerontologists and added on to the existing 
questionnaire of the larger study. A pretest comprising a dozen couples with an Alzheimer 
spouse suggested a few minor adjustments of the questionnaire. Patients and caregivers are 
from the Zurich metropolitan area in Switzerland and were interviewed between 
September 2000 and August 2002. Since more than 90 percent of the caregivers are 
spouses, we restrict the present analysis to couples to make the sample more homogeneous. 
The sample thus contains 126 pairs of patients with dementia and their spouse caregivers.  
The WTP information comes from face-to-face interviews with patients and their 
caregivers. There is now wide agreement in the literature that face-to-face interviewing is 
the preferred method for obtaining reliable answers to WTP questions (Mitchell & Carson 
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1989, Ch. 5; Olsen & Smith 2001). In the present study, it had the benefit of keeping the 
difficulty of understanding low. Caregivers and their demented relatives were interviewed 
separately by a study nurse and a physician at the same time. They had to state their WTP 
independently of each other without any possibility of contact. Caregivers and patients 
answered the same questions, involving identical treatments and offered bids. A 
randomization of bids to prevent sequencing effects was not performed because the 
possible biases would be similar in the two groups; they should therefore be of limited 
relevance when the objective is to compare the WTP values of patients and caregivers.  
The questions about WTP were put in two different ways. First, a payment card format 
was used, with prices of 5000, 10,000, 20,000, 50,000, 100,000, 150,000, 200,000, and 
500,000 Swiss francs (CHF; 1 CHF = 0.7 US$ at 2003 exchange rates) for every 
hypothetical treatment. The lower limit of the interval is given by the amount where the 
respondent still answers with “yes” and the upper limit by the amount where he or she 
switches to "rather yes", "not sure",  "rather no" or “no”. WTP values are simply equaled to 
interval midpoints. For example, a respondent saying “yes” at the amount of CHF 10,000 
and switching to one of the other categories at CHF 20,000 is assigned a WTP of CHF 
15,000. Respondents not willing to pay the lowest offered bid of CHF 5,000 are assigned a 
WTP of zero. While this biases aggregate WTP values towards zero, the bias occurs in 
both the patient and the caregiver group, with limited effect on the differences between 
then, the statistic of primary interest. Individuals answering “yes” at the highest proposed 
amount (CHF 500,000) were asked to specify the maximum amount they were willing to 
pay for the treatment. The second way to obtain WTP information was to ask respondents 
to directly state the maximum percentage of their wealth they were willing to give up to 
buy the hypothetical treatment. This order of the two approaches was chosen because 
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several studies had shown that direct WTP questions create more non-responses and 
protest (Klose, 1999).  
An alternative format would have been the “take-it-or-leave-it” approach. This is a very 
popular elicitation technique in contingent valuation surveys because it mimics a market 
transaction, where people are accustomed to deciding whether or not to buy a good at a 
specific fixed price. However, this alternative has an important drawback. It is inefficient 
in that more observations are needed for the same level of statistical precision because only 
a discrete indicator of maximum WTP is obtained rather than the actual maximum WTP 
amount (Mitchell and Carson 1989, Ch. 4). This loss of efficiency weighs heavily in view 
of the small number of respondents in this study.  
On the other hand, the payment card format is vulnerable to range bias. This bias is to 
be expected if respondents consider the range of presented amounts as reflecting 
researcher’s knowledge about WTP values, causing them to use it as a frame of reference 
in answering the WTP question (Mitchell & Carson 1989, Ch. 11). Because of the 
smallness of the sample, it was not possible to control for range bias by confronting groups 
of subjects with different price ranges.  
However, for the analysis of differences between the WTP of caregivers and patients, a 
potential range bias is not a major problem. Caregivers and patients receive the same bids. 
Thus, potential range bias in the direction of the offered bids would favor the null 
hypothesis of no difference between the WTP of caregivers and patients.  
As noted above, respondents were also asked to state their WTP as a maximum 
percentage of wealth. This is the preferred measure because stated WTP for hypothetical 
treatment could be very high. However, WTP is likely to be influenced by ability to pay, 
which is limited by wealth. In accordance with Chiu et al. (1998), we conclude that in the 
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context of high WTP values, the percentage of wealth appears to be a more meaningful 
measure than the absolute amount of money. This second WTP question was open-ended, 
so caregivers and patients directly stated the share of wealth they were willing to sacrifice. 
Therefore, these answers can be used to estimate WTP without any modification.  
Data 
Only 36 percent of patients are female. This low percentage results from the fact that 
only patients living at home and cared for by relatives were included in the study. The age 
of patients ranges from 52 to 91, with a mean of 75 years. The youngest caregiver is 42 and 
the oldest, 90 years old, with mean age at 71 years. On average, patients are thus 4 years 
older than their caregivers. 31 percent of patients have a Clinical Dementia Rating (CDR) 
score higher than 6. The CDR is a measure of care recipients’ impairment (Hughes, Berg 
& Danzinger, 1982), has scores from 0 to 18, and is widely used in studies to gauge 
dementia progression. 
Household wealth ranges from zero to CHF 10 million. Mean and median wealth are 
CHF 614,000 (US$ 430,000) and CHF 300,000 (US$ 210,000), respectively, indicating 
considerable skewness in the distribution of wealth. Out of the 95 caregivers, 17 percent 
are employed full-time or part-time. The employment status of the caregiver influences his 
or her opportunity cost of caregiving.   
Results 
Only couples that both answered the WTP questions are included in the analysis. 
Therefore, there is a one-to-one relationship between patients and caregivers.  
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Mean and Median WTP 
Panel A of Table 1 shows results for mean and median WTP, measured as a share of 
wealth. To just prevent future worsening (Stabilization), patients are willing to sacrifice an 
average of 14 percent of their wealth, to be completely cured (Cure) an average of 22 
percent, and to get relief for caregivers (No burden), 22 percent. The corresponding values 
for caregivers amount to 24 percent for Stabilization, 31 percent for Cure, and 18 percent 
for No Burden, respectively. Differences between the three treatments therefore are 
reflected in differences in WTP values, which therefore may mirror preferences in both 
groups. 
In the payment card format, patients are willing to pay CHF 11,500 (US$ 8,100) for 
Stabilization, CHF 31,000 (US$ 21,700) for Cure, and CHF 33,100 (US$ 23,200) for No 
burden, respectively (panel B). The mean values for caregivers are much higher, viz. CHF 
104,000 (US$ 72,800) for Stabilization, CHF 175,600 (US$ 123,000) for Cure, and CHF 
52,900 (US$ 37,000) for No burden. Median values are lower throughout, pointing to 
considerable skewness in the distribution of WTP scores. In fact, the mean for caregivers is 
strongly influenced by one respondent who was willing to pay CHF 4 mn. (US$ 2.8 mn.) 
for Stabilization or Cure. On the whole, WTP values seem to be associated with 
differences in treatment that are relevant for preferences, justifying the use of WTP 
measures in the tests that follow. 
Also, the Assumption stated in the Methods section need not be rejected, at least with 
regard to WTP expressed as a share of wealth. In panel A of Table 1, WTP values of 
caregivers are not consistently higher than those of patients across the three treatments 
(and only insignificantly so in panel B, according to median values and Wilcoxon test 
statistics). Therefore, deriving the hypotheses concerning differences between patients and 
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caregivers (HDE, HDA) from differences in the ranking of treatments (HTE, HTA) can be 
justified. 
Ranking of Treatment Alternatives 
For WTP as a share of wealth (see panel A of Table 1, horizontal comparison), we use t 
tests to determine whether the differences between the three treatments are significant. 
Patient WTP for Stabilization is significantly lower than for both Cure (t = 3.9) and No 
burden (t = 3.1), while there is no statistical difference between Cure and No burden (t = 
0.1). Caregivers also value Stabilization significantly less than Cure. Contrary to patients, 
however, they put a higher value on Stabilization than on No burden (t = 3.3).  
As the distribution of the WTP in money amounts is skewed, we use the Wilcoxon signed 
rank test to evaluate the differences between the median values of the three treatments (see 
panel B of Table 1). The results are very similar to the results based on the share of wealth. 
The only difference is that for caregivers, median WTP for Stabilization and WTP for No 
burden are not statistically different.  
Predicted and observed rankings are juxtaposed in Table 2. With regard to the three 
treatments (panel A), patients rank them as predicted by HTA, suggesting full altruism. In 
particular, patients do not exhibit WTP for Cure in excess of No burden. Therefore, 
patient’s WTP consists of the indirect component only (see Figure 1 again). As to 
caregivers, the observed ranking again conforms to HTA rather than HTE, pointing to 
altruism. Specifically, caregivers do have a WTP for Cure in excess of No burden. This 
difference amounts to WTP for improving patient’s health – the indirect component again. 
Their total WTP for Cure consists of about 60 percent for the reduction of their own 
burden (17.5/30.7 in panel A of Table 1) and 40 percent for improving their partner’s 
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health ((30.7 – 17.5)/30.7). Taken together, the results for patients and caregivers can be 
summarized in the provocative conclusion that curing dementia is only for the caregiver. 
Differences Between Patients’ and Caregivers’ WTP 
According to panel A of Table 1 (vertical comparison), WTP as a share of wealth is 
significantly lower among patients than caregivers for both Stabilization (t = 3.2) and Cure 
(t = 2.5). However, there is no significant difference between patients and caregivers for 
No Burden (t = 1.2). In money amounts, the median WTP of patients is significantly lower 
than that of caregivers for all three treatments (panel B). Since the share of wealth is the 
preferred indicator, the first ranking is entered as “observed” in panel B of Table 2. With 
one (insignificant) exception, HDA is confirmed and HDE contradicted, in accordance 
with perfect altruism on the part of both patients and caregivers. 
One possible explanation for the lower observed WTP of patients could be that they 
have a higher rate of protest zeroes. Indeed, patients and caregivers differ in their number 
of zero responses. Among patients, a full 30 percent do not want to pay the minimum 
proposed amount of CHF 5,000 for Cure, possibly reflecting protest zeroes. Among 
caregivers, there are only three refusals. Refusals are more frequent for the two other, less 
valued alternatives, as one would expect of true zeroes. To control for the influence of 
protest zeroes, we excluded all couples with zero values. This amounts to assuming that all 
zeroes are protest zeroes and favors the null hypothesis that there is no difference between 
patients and caregivers. However, this exclusion does not affect the observed rankings of 
Table 2 and hence the evidence in favor of mutual altruism.   
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Discussion 
In this study, 126 pairs of Alzheimer patients and their spouse caregivers stated their 
willingness-to-pay (WTP) for three hypothetical treatments of dementia. A first major 
result is that measured WTP may reflect preferences for these treatments both of caregivers 
and patients, in spite of cognitive impairment due to Alzheimer among the latter. For, 
differences in the characteristics of the proposed treatments clearly go along with 
differences in WTP values. A possible objection to this first conclusion is that the WTP 
values obtained especially for Cure are too low, amounting to less than one third of wealth 
on average (see Table 1, panel A). As dementia is a fatal disease, should respondents not 
be willing to spend their entire wealth for curing it?  
Of course, the estimation presented may fall short of true values, but there are several good 
reasons for the true values to remain below wealth, in keeping with economic theory 
(Jones-Lee et al. 1985; Thaler and Rosen 1975). First, most patients are old. Therefore, 
curing dementia only means prolonging life for a few years. Second, because of age and 
other diseases, quality of life during these additional years may be low. Third, all 
participants in this study have a spouse, who on average is four years younger. Spending 
money on treatment thus means reducing the material welfare of a spouse who has less 
resources available per period to begin with. Fourth, most of the patients and caregivers are 
retired, usually without the possibility to relax the wealth constraint by earning additional 
income. During the face-to-face interviews, respondents mentioned these points when 
searching for their maximum WTP.  
The second main finding is that the structure of the WTP values obtained points to 
mutual altruism. From the literature (e.g. Liu et al., 2000), unilateral altruism on the part of 
the (parent) caregiver in favor of the child is an established fact. However, this study 
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suggests the existence of altruism also on the part of patients. First, their ranking of the 
three treatments is predicted by the altruism hypothesis HTA while contradicting the 
egoism alternative HTE (see Table 2 again). Specifically, patients put No burden first; they 
worry more about the burden of their spouse caregivers than their own health. Second, 
compared to their caregivers, they value the treatments again as predicted by the altruism 
hypothesis HDA rather than HDE. In particular, they are willing to pay the same amount as 
their caregiving spouses for the No burden alternative but less for the Cure and 
Stabilization options, which clearly would be in their self-interest. 
Caregivers’ altruism is documented by both rankings as well. They put the Cure 
alternative first and No burden last, although the two are equivalent in terms of their own 
situation; this is in accordance with HTA in Table 2. In addition, the fact that they are not 
willing to pay more than their spouse patients for the No burden therapy (HDA) points in 
the same direction. 
Of course, hypothetical treatments being associated with hypothetical payments, there 
is always scope for inflating stated WTP.  This tendency must be expected in particular 
when the alternative considered (helping a patient or a caregiver) is socially accepted 
(“yea-saying”, “warm glow”, see e.g. Blamey et. al., 1999). One can justifiably doubt that 
either partner of the couple would in fact sacrifice one third (or even more) of his or her 
fortune to have Alzheimer cured. Such an effect may indeed inflate patients’ WTP 
sufficiently to exceed that of caregivers in the case of No burden, creating spurious 
evidence in favor of altruism. However, it is far from clear that the same effect should 
result in the equivalence element in the ranking No burden = Cure > Stabilization 
predicted by altruism (HTA in panel A of Table 2). On the whole, it seems difficult to 
explain the full set of observed rankings with reference to bias in WTP estimation. 
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Conclusions 
Alzheimer patients constitute a group in society that importantly depends on informal 
care. Altruism is a likely motive to provide such care and has been established in parent-
child relationships. In the context of Alzheimer disease, however, both patient and spouse 
caregiver are in similar (advanced) age. Their altruism might therefore be mutual, although 
the patient cannot express it easily through his or her activity. 
An experiment with 126 Alzheimer patients and their caregiving spouses living in the 
Zurich (Switzerland) metropolitan area was conducted in 2000 – 2002 to throw light on 
this issue by confronting them with three hypothetical therapies, Stabilization, Cure, and 
No burden (for caregivers). The objectives were to find out whether preferences are 
reflected in the economic concept of willingness-to-pay (WTP) and to test whether the 
rankings of WTP values obtained conform to full altruism, in the sense that the patient 
adopts the preferences of the caregiver and vice versa. 
The WTP values derived from the experiment consistently reflect differences in the 
characteristics of the three treatments, suggesting that they do mirror preferences. Also, 
these WTP values exhibit rankings that conform to the altruism hypothesis but contradict 
the egoism hypothesis both for patients and caregivers. First, patients rate No burden and 
Cure as equivalent (although No burden would not improve their health), while caregivers 
have maximum WTP for Cure (although this would not benefit them as much as No 
burden). Second, caregivers and patients are prepared to pay the same amount for No 
burden, whereas caregivers value Cure (in the interest of their spouse patients) higher than 
patients themselves. The startling implication is that curing Alzheimer disease would 
benefit caregivers rather than patients. 
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 Figure 1. Direct and indirect effects of curing dementia 
 Effects of treatment Patient’s WTP  Caregiver’s WTP  
 Improved health status of 
the patient 
Direct effect Indirect effect  
 
 




Direct effect  




Table 1. Willingness-to-pay in percentage and money amounts of wealth 
  Stabilization Testa) Cure Testa) No 
burden 
Testa)
A. Share of wealth (%):   
 Mean Patients 13.8 3.9** 21.6 0.1 21.9 3.1**
 Testa) 3.2** 2.5** 1.2 
 Caregivers 23.9 4.4** 30.7 5.9** 17.5 3.3**
 Median Patients 10.0 10.0 10.0 
 Caregivers 10.0 20.0 10.0 
Patients 2.1 2.8 2.9  SD 
    (Mean) Caregivers 2.7 3.0 2.1 
Number of observations 96 95 94 
B. Money amount (CHF):   
 Mean Patients 11,500 31,000 33,100 
 Caregivers 104,000 7.1** 175,600 6.6** 52,900 1.5
 Median Patients 0 6.1** 7,500 0.1 7,500 4.9**
 Testa) 6.7** 6.2** 2.9** 
 Caregivers 15,000 35,000 15,000 
Patients 2,700 7,300 8,900     SD  
   (Mean) Caregivers 39,400 42,100 10,000 
 Number of observations 104 103 101
a) t statistics (absolute values) for mean shares of wealth; Wilcoxon statistics for 
median money amounts; *: p < 0.05, **: p < 0.01. 
b) Comparing No burden to Stabilization 
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Table 2. Predicted and actual rankings 
 Hyp. Predicted Observed 
(from Table 1) 
A. Treatments 
HTE Cure > Stabilization > No burden WTP of  
patients HTA No burden = Cure > Stabilization 
No burden = Cure > 
Stabilization 
HTE No burden = Cure > Stabilization WTP of  
Caregivers HTA Cure > Stabilization > No burden 
Cure > Stabilization 
> No burden 
 
B. Differences, patients. vs. caregivers 
HDE Patients > Caregivers WTP for 
Stabilization HDA Patients < Caregivers 
 
Patients < Caregivers
HDE Patients > Caregivers WTP for  
Cure HDA Patients < Caregivers 
 
Patients < Caregivers
HDE Patients < Caregivers WTP for 







 Exhibit: Elements of the Questionnaire 
Stabilization: Imagine that further cognitive impairment of your spouse could be prevented 
using a very expensive treatment that is not covered by health insurance. Thus there would 
be no further deterioration -- but no improvement either! 
Cure: Imagine that the cognitive impairment of your spouse could be reverted using a very 
expensive treatment that is not covered by health insurance, resulting in the situation that 
obtained before the onset of the illness. 
No burden: Imagine that there are ways not covered by health insurance to reduce your 
burden caused by the cognitive impairment of your spouse (which might become even 
more marked in the future), resulting in a burden as is usual between healthy partners. 
All treatments: Would you want to opt for this treatment if you had to pay the following 
amounts just once ? Please consider that you will have that much less to spend for other 
purposes! Bids offered: 5000, 10,000, 20,000, 50,000, 100,000, 150,000, 200,000, and 
500,000 Swiss francs. Answers offered: yes, rather yes, not sure, rather no, no. 
All treatments: What percentage of your wealth would you be willing to pay for such a 
treatment? 
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